Semler Scientific Inc. (SMLR)
Stock Price:
$62.00 USD
4.00 (6.90%)
Updated Oct 22, 2020 3:59 PM EDT - Market closed
Key Info
| Market Cap |
407.78M |
| Revenue (ttm) |
33.86M |
| Net Income (ttm) |
14.36M |
| Shares Out |
6.58M |
| EPS (ttm) |
1.80 |
| PE Ratio |
34.44 |
| Forward PE |
n/a |
| Dividend |
n/a |
| Dividend Yield |
n/a |
Stock Quote
| Trading Day |
Oct 22, 2020 |
| Last Price |
$62.00 |
| Previous Close |
$58.00 |
| Change ($) |
4.00 |
| Change (%) |
6.90% |
| Day's Open |
58.00 |
| Day's Range |
57.51 - 62.00 |
| Day's Volume |
8,960 |
| 52-Week Range |
30 - 58 |
More Stats
| Market Cap |
407.78M |
| Enterprise Value |
394.13M |
| Earnings Date (est) |
Nov 5, 2020 |
| Ex-Dividend Date |
n/a |
| Shares Outstanding |
6.58M |
| Float |
4.65M |
| EPS (basic) |
2.20 |
| EPS (diluted) |
1.80 |
| FCF / Share |
2.29 |
| Dividend |
n/a |
| Dividend Yield |
n/a |
| Earnings Yield |
2.90% |
| FCF Yield |
3.68% |
| Payout Ratio |
n/a |
| Shares Short |
80,062 |
| Short Ratio |
1.95 |
| Short % of Float |
1.72% |
| Beta |
0.99 |
| PE Ratio |
34.44 |
| Forward PE |
n/a |
| P/FCF Ratio |
27.19 |
| PS Ratio |
12.04 |
| PB Ratio |
21.33 |
| Revenue |
33.86M |
| Operating Income |
10.57M |
| Net Income |
14.36M |
| Free Cash Flow |
15.00M |
| Net Cash |
13.65M |
| Net Cash / Share |
2.07 |
| Gross Margin |
85.97% |
| Operating Margin |
31.22% |
| Profit Margin |
42.40% |
| FCF Margin |
44.29% |
| ROA |
42.33% |
| ROE |
123.58% |
| ROIC |
224.40% |
Stats based on trailing-twelve-month (ttm) numbers.
Analyst Summary
Analyst Ratings (0)
| Buy |
0 |
| Overweight |
0 |
| Hold |
0 |
| Underweight |
0 |
| Sell |
0 |
Price Target
$69.00*
(11.29% upside)
Low
61.0
Current: $62.00
High
75.0
Target: 69.00
*Average 12-month price target from 3 stock analysts.
Financial Performance
Financial numbers in millions USD.
Financial Overview
| Year | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|
| Revenue | 32.77 | 21.49 | 12.45 | 7.43 | 7.00 | 3.64 | 2.27 |
| Revenue Growth | 52.47% | 72.59% | 67.5% | 6.18% | 92.6% | 59.85% | - |
| Gross Profit | 29.11 | 18.79 | 9.90 | 5.56 | 4.15 | 2.94 | 1.81 |
| Operating Income | 10.71 | 5.34 | -0.85 | -2.16 | -8.42 | -4.34 | -2.12 |
| Net Income | 15.08 | 5.01 | -1.51 | -2.55 | -8.50 | -4.52 | -2.23 |
| Shares Outstanding | 6.44 | 6.08 | 5.41 | 5.12 | 4.93 | 4.11 | 0.79 |
| Earnings Per Share | 1.88 | 0.66 | -0.28 | -0.50 | -1.72 | -1.10 | -2.84 |
| EPS Growth | 184.85% | - | - | - | - | - | - |
| Operating Cash Flow | 12.73 | 4.70 | 0.62 | -1.80 | -4.14 | -3.82 | -1.19 |
| Capital Expenditures | -0.17 | -0.14 | -0.04 | -0.22 | -0.53 | -0.01 | - |
| Free Cash Flow | 12.55 | 4.56 | 0.58 | -2.03 | -4.67 | -3.83 | -1.19 |
| Cash & Equivalents | 7.74 | 3.28 | 1.46 | 0.62 | 0.41 | 6.26 | 0.73 |
| Total Debt | - | - | 2.92 | 2.61 | - | 2.00 | 0.27 |
| Net Cash / Debt | 7.74 | 3.28 | -1.47 | -1.99 | 0.41 | 4.26 | 0.46 |
| Assets | 18.29 | 7.72 | 4.24 | 3.07 | 3.08 | 7.50 | 1.72 |
| Liabilities | 5.21 | 3.52 | 6.82 | 5.99 | 4.15 | 4.06 | 2.02 |
| Book Value | 13.07 | 4.20 | -2.58 | -2.92 | -1.07 | 3.44 | -0.30 |
Numbers in millions USD, except per-share numbers.
Company Details
| Full Name |
Semler Scientific Inc. |
| Country |
United States |
| Employees |
67 |
| CEO |
Douglas R. Murphy-Chutorian |
Stock Information
| Ticker Symbol |
SMLR |
| Stock Exchange |
US OTC |
| Sector |
Healthcare |
| Industry |
Medical Devices |
| Unique Identifier |
OTCMKTS: SMLR |
| IPO Date |
February 21, 2014 |
Description
Semler Scientific develops, manufactures, and markets proprietary products that assist healthcare providers to evaluate and treat patients with chronic diseases in the United States. Its products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition. The company's products serve cardiologists, internists, nephrologists, endocrinologists, podiatrists, and family practitioners, as well as healthcare insurance plans, integrated delivery networks, independent physician groups, and companies contracting with the healthcare industry, such as risk assessment groups. It offers its products through salespersons and distributors. Semler Scientific, Inc. was founded in 2007 and is headquartered in San Jose, California.